These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3607820)

  • 1. Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension.
    Maxwell MH; Garrett BN; Saunders E; Schnaper H
    Clin Ther; 1987; 9(4):380-9. PubMed ID: 3607820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
    Fogari R; Zoppi A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
    Salako LA; Falase AO; Aderounmu AF; Walker O
    Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
    Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
    Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)].
    Widimský J; Lánská V; Hulínský V; Balazovjech I; Havlík V; Havránek P; Kroupa E; Nikodýmová L; Pátek F; Svítil F; Svihovcová P
    Vnitr Lek; 1996 Apr; 42(4):223-8. PubMed ID: 8693706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza V; Picardi L; Romano M; Parini J
    Arzneimittelforschung; 1985; 35(3):623-5. PubMed ID: 2859865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
    Leonetti G; Pasotti C; Capra A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
    Nissinen A; Tuomilehto J
    Pharmatherapeutica; 1980; 2(7):462-8. PubMed ID: 7010382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of atenolol (Tenormin) and the combined preparation atenolol/chlorthalidone (Tenoretic Mite) in essential hypertension. A randomized double-blind study from general practice].
    Pilgaard S; Palmelund VO; Svendsen TL
    Ugeskr Laeger; 1990 Apr; 152(15):1083-6. PubMed ID: 2184556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valsartan alone and as part of combination therapy in general practice in Brazil.
    Madi JC; Oigman W; Franco R; Armaganijan D;
    Int J Clin Pract; 2001 Oct; 55(8):520-3. PubMed ID: 11695071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
    Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
    Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle].
    Chieppa S; Lobascio C; Brandini V; Iarussi D; Giuliani F; Langella S; De Simone R
    Cardiologia; 1989 Aug; 34(8):695-9. PubMed ID: 2605580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term antihypertensive efficacy of ketanserin plus chlorthalidone.
    Fasano ML; Soro S; Ferrara LA
    Drugs Exp Clin Res; 1989; 15(11-12):587-90. PubMed ID: 2700322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.
    Cruickshank JM; Pennert K; Sörman AE; Thorp JM; Zacharias FM; Zacharias FJ
    J Hypertens; 1987 Aug; 5(4):489-98. PubMed ID: 3668249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.